CTOs on the Move

Neovasc

www.neovasc.com

 
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.neovasc.com
  • 13562 Maycrest Way #5138
    Richmond, BC CAN V6V 2J7
  • Phone: 604.270.4344

Executives

Name Title Contact Details

Funding

Neovasc raised $12M on 05/14/2019
Neovasc raised $10M on 01/11/2020
Neovasc raised $72M on 02/10/2021

Similar Companies

Atg-designing Mobility Inc

Atg-designing Mobility Inc is a Cerritos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aulisa

Aulisa Medical USA, Inc., located in Palo Alto, integrates medical device science and information communication technologies to provide smart medical solutions for the evolving patient care landscape. The company specializes in wireless, wearable, FDA-cleared vital-signs measuring devices with continuous, cloud-based, patient monitoring and alarm systems. Through the development of new products, Aulisa continues to focus on growing the application of Digital Health, collecting large amounts of patient data for big data analytics and Artificial Intelligence (AI) to medical applications. The company is a subsidiary of Taiwan Aulisa Medical Devices Technologies, Inc., headquartered in Taipei, Taiwan, where a Research & Development center and operational headquarters was established in 2013.

Sciton, Inc

Sciton, Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Insulet

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet`s Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.

IRIS International

IRIS International, Inc. develops, manufactures and markets in vitro diagnostic (IVD) products, including IVD imaging systems based on neural network-based automated particle recognition (APR) software to enable high-speed digital processing to classify